Gyre Therapeutics (GYRE) Free Cash Flow Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 24.91% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 20.11% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.71% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -10.65% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 31.42% |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn | -29.64% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29.64% |
| Dec 31, 2025 | -28.78% |
| Sep 30, 2025 | 36.45% |
| Jun 30, 2025 | 29.11% |
| Mar 31, 2025 | 72.49% |
| Dec 31, 2024 | 46.59% |
| Sep 30, 2024 | 26.97% |
| Jun 30, 2024 | 29.84% |
| Mar 31, 2024 | 28.24% |
| Dec 31, 2023 | 26.97% |
| Sep 30, 2023 | 34.35% |
| Jun 30, 2023 | 28.78% |
| Mar 31, 2023 | 56.11% |
| Dec 31, 2022 | 93.36% |
| Sep 30, 2022 | 7.18% |
| Jun 30, 2022 | -2.21% |
| Mar 31, 2022 | 6.98% |
| Dec 31, 2021 | -24.38% |
| Sep 30, 2021 | -46.53% |
| Jun 30, 2021 | -39.48% |
| Mar 31, 2021 | -66.20% |
| Dec 31, 2020 | -51.68% |
| Sep 30, 2020 | -38.88% |
| Jun 30, 2020 | -50.99% |
| Mar 31, 2020 | -3.83% |
| Dec 31, 2019 | -16.62% |
| Sep 30, 2019 | -21.05% |
| Jun 30, 2019 | -43.74% |
| Mar 31, 2019 | -45.78% |
| Dec 31, 2018 | -20.58% |
| Sep 30, 2018 | 9.99% |
| Jun 30, 2018 | -75.71% |
| Mar 31, 2018 | -21.20% |
| Dec 31, 2017 | -45.46% |
| Sep 30, 2017 | -31.11% |
| Jun 30, 2017 | 20.95% |
| Mar 31, 2017 | 33.86% |
| Dec 31, 2016 | -30.44% |
| Sep 30, 2016 | 19.15% |
| Jun 30, 2016 | 28.11% |
| Mar 31, 2016 | 19.86% |
| Dec 31, 2015 | 23.70% |
| Sep 30, 2015 | 2.55% |
| Jun 30, 2015 | 57.19% |
| Mar 31, 2015 | 50.75% |
| Dec 31, 2014 | 53.73% |
| Sep 30, 2014 | 45.25% |
| Jun 30, 2014 | 27.59% |
| Mar 31, 2014 | 13.13% |
| Dec 31, 2013 | 49.48% |
| Sep 30, 2013 | 17.33% |